This study aims to examine the effects of lymphedema extremity on upper extremity function, posture and quality of life in patients who develop upper extremity lymphedema after unilateral breast cancer. Twenty-seven volunteers (27Female) diagnosed with upper extremity lymphedema after unilateral breast cancer treatment by a specialist physician between May 2022 and October 2022 were included in the study. Upper extremity circumference measurements of the individuals were performed on the healthy and affected sides. A goniometer measured both sides' upper extremity range of motion (ROM). The New York Posture Analysis (NYPA) was used for posture evaluation. Upper extremity functions were assessed by the Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire and the Lymphedema Functionality, Disability and Health Questionnaire (Lymph-ICF). Quality of life was assessed by Upper Extremity Lymphedema-27 (ULL-27) and Quality of Life Measure for Limb Lymphedema -Arm (LYMQOL- Arm).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Disabilities of the Arm, Shoulder, and Hand (DASH)
Timeframe: 10 minutes
Lymphedema Functionality, Disability, and Health Questionnaire (Lymph-ICF)
Timeframe: 10 minutes
Upper Extremity Lymphedema-27 (ULL-27)
Timeframe: 10 minutes
Quality of Life Measure for Limb Lymphedema-Arm (LYMQOL-Arm)
Timeframe: 10 minutes
The New York Posture Analysis (NYPA)
Timeframe: 5 minutes